Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients.

@article{Ives2004MonoamineOT,
  title={Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients.},
  author={Natalie Ives and Rebecca L Stowe and Joanna Marro and Carl E. Counsell and Angus Macleod and Carl E Clarke and Richard Dawson Gray and Keith Wheatley},
  journal={BMJ},
  year={2004},
  volume={329 7466},
  pages={593}
}
OBJECTIVE To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease. DATA SOURCES Searches of the Cochrane Library, Medline, Embase, PubMed, and Web of Science for years 1966-2003, plus major journals in the field, abstract books, and proceedings of meetings, for randomised trials comparing MAOBIs with placebo or levodopa. DATA EXTRACTION Available data on mortality, motor complications, side effects, treatment compliance… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Effect of adding selegiline to levodopa in early , mild Parkinson ’ s disease : formal systematic review of data on patients in all relevant trials is required

  • K Dickersin, R Scherer, C Lefebvre
  • BMJ
  • 1998

Effect of selegiline on mortality in patients with Parkinson ’ s disease : a meta - analysis

  • C Counsell
  • 1998

Meta - analysis of 5038 patients in 28 randomised trials comparing dopamine agonists with levodopa

  • R Fitzpatrick, V Peto
  • 1998

Similar Papers

Loading similar papers…